The cross-sectional association of cognition with diabetic peripheral and autonomic neuropathy-The GRADE study.


Journal

Journal of diabetes and its complications
ISSN: 1873-460X
Titre abrégé: J Diabetes Complications
Pays: United States
ID NLM: 9204583

Informations de publication

Date de publication:
12 2021
Historique:
received: 30 07 2021
revised: 10 09 2021
accepted: 10 09 2021
pubmed: 25 9 2021
medline: 11 1 2022
entrez: 24 9 2021
Statut: ppublish

Résumé

Studies examining whether measures of cognition are related to the presence of diabetic peripheral neuropathy (DPN) and/or cardiovascular autonomic neuropathy (CAN) are lacking, as are data regarding factors potentially explaining such associations. Participants were from the Glycemia Reduction Approaches in Diabetes Study (GRADE) that examined 5047 middle-aged people with type 2 diabetes of <10 years of known duration. Verbal learning and immediate and delayed recall (memory) were assessed with the Spanish English Verbal Learning Test; frontal executive function and processing speed with the Digit Symbol Substitution Test; and ability to concentrate and organize data with word and animal fluency tests. DPN was assessed with the Michigan Neuropathy Screening Instrument and CAN by indices of heart rate variability (standard deviation of normal beat to beat variation [SDNN] and root mean square of successive differences [RMSSD]). DPN was significantly inversely related to measures of immediate recall and processing speed. The percent of cognitive variation explained by DPN was small. Tests of CAN had an inconsistent or absent association with measures of cognition. Higher waist circumference and urine albumin creatinine (UACR) levels were the strongest correlates in the relationship between DPN and cognitive impairment. DPN, but not CAN, was cross-sectionally associated with lower performance in measures of cognition in people with type 2 diabetes of <10 years of known duration. Greater waist circumference and UACR were important variables in this association. The mechanisms underlying the cross-sectional association of DPN with cognitive impairment are unknown. Clinicaltrials.gov: NCT01794143.

Sections du résumé

BACKGROUND
Studies examining whether measures of cognition are related to the presence of diabetic peripheral neuropathy (DPN) and/or cardiovascular autonomic neuropathy (CAN) are lacking, as are data regarding factors potentially explaining such associations.
METHODS
Participants were from the Glycemia Reduction Approaches in Diabetes Study (GRADE) that examined 5047 middle-aged people with type 2 diabetes of <10 years of known duration. Verbal learning and immediate and delayed recall (memory) were assessed with the Spanish English Verbal Learning Test; frontal executive function and processing speed with the Digit Symbol Substitution Test; and ability to concentrate and organize data with word and animal fluency tests. DPN was assessed with the Michigan Neuropathy Screening Instrument and CAN by indices of heart rate variability (standard deviation of normal beat to beat variation [SDNN] and root mean square of successive differences [RMSSD]).
RESULTS
DPN was significantly inversely related to measures of immediate recall and processing speed. The percent of cognitive variation explained by DPN was small. Tests of CAN had an inconsistent or absent association with measures of cognition. Higher waist circumference and urine albumin creatinine (UACR) levels were the strongest correlates in the relationship between DPN and cognitive impairment.
CONCLUSION
DPN, but not CAN, was cross-sectionally associated with lower performance in measures of cognition in people with type 2 diabetes of <10 years of known duration. Greater waist circumference and UACR were important variables in this association. The mechanisms underlying the cross-sectional association of DPN with cognitive impairment are unknown. Clinicaltrials.gov: NCT01794143.

Identifiants

pubmed: 34556408
pii: S1056-8727(21)00261-0
doi: 10.1016/j.jdiacomp.2021.108047
pmc: PMC8608739
mid: NIHMS1745416
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01794143']

Types de publication

Clinical Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108047

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002529
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK111022
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000439
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002378
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001425
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002243
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002345
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States
Organisme : NIDDK NIH HHS
ID : U34 DK088043
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002537
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK092926
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002535
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK072476
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK079626
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001409
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK098246
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001449
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002489
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM104940
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001108
Pays : United States
Organisme : NIDDK NIH HHS
ID : P60 DK079626
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020541
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK081373
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK017047
Pays : United States

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Références

Curr Opin Lipidol. 2020 Feb;31(1):1-7
pubmed: 31815755
Ann N Y Acad Sci. 2015 Sep;1353:60-71
pubmed: 26132277
J Clin Psychopharmacol. 2018 Oct;38(5):513-519
pubmed: 30124583
JAMA. 2012 May 9;307(18):1941-51
pubmed: 22570462
Neurology. 2011 Sep 27;77(13):1276-82
pubmed: 21947532
Neuropsychiatr Dis Treat. 2011;7:465-84
pubmed: 21857787
Clin Neuropsychol. 2002 Dec;16(4):439-51
pubmed: 12822053
Diabetes Care. 2020 Apr;43(4):806-812
pubmed: 32029635
J Int Neuropsychol Soc. 2014 Mar;20(3):278-91
pubmed: 24555960
J Am Geriatr Soc. 2012 Jun;60(6):1057-63
pubmed: 22690982
Diabetes Care. 1996 May;19(5):509-13
pubmed: 8732720
Int J Low Extrem Wounds. 2019 Sep;18(3):294-300
pubmed: 31307246
Diabetes Care. 2010 Feb;33(2):434-41
pubmed: 20103559
Diabetes Res Clin Pract. 1995 Nov;30(2):101-10
pubmed: 8833630
Diabetol Metab Syndr. 2015 Jun 07;7:51
pubmed: 26075029
Neuroepidemiology. 2008;31(2):115-21
pubmed: 18667838
Diabetes Care. 2009 May;32(5):894-6
pubmed: 19244093
J Intensive Care Soc. 2020 May;21(2):148-157
pubmed: 32489411
J Endocrinol Metab. 2019 Aug;9(4):82-89
pubmed: 32411312
J Electrocardiol. 2016 Sep-Oct;49(5):686-90
pubmed: 27396499
J Neurol Sci. 2008 Jan 15;264(1-2):157-62
pubmed: 17850822
Diabetes Care. 2013 Aug;36(8):2254-61
pubmed: 23690531
Acta Diabetol. 2020 Sep;57(9):1073-1080
pubmed: 32266492
Diabetes Care. 2017 Jan;40(1):136-154
pubmed: 27999003
Arch Phys Med Rehabil. 2013 Jun;94(6):1074-9
pubmed: 23385112
Neuropsychologia. 2017 May;99:148-155
pubmed: 28257876
Diabetes Care. 2019 Nov;42(11):2098-2107
pubmed: 31391203
Diabetes Care. 2018 Dec;41(12):2586-2594
pubmed: 30305347
JAMA Neurol. 2016 Dec 1;73(12):1468-1476
pubmed: 27802497
J Neurol Phys Ther. 2014 Apr;38(2):104-10
pubmed: 24384943
Br J Psychiatry. 1984 Sep;145:263-8
pubmed: 6478119
Diabetologia. 2005 Dec;48(12):2460-9
pubmed: 16283246
J Diabetes Complications. 2021 Mar;35(3):107805
pubmed: 33288412
Diabet Med. 2012 Jul;29(7):937-44
pubmed: 22417277
Am J Physiol Heart Circ Physiol. 2017 Jan 1;312(1):H1-H20
pubmed: 27793855
Diabetes. 2018 Sep;67(9):1729-1741
pubmed: 30135134
PLoS One. 2018 Jan 5;13(1):e0190699
pubmed: 29304099
PLoS One. 2014 Oct 17;9(10):e108784
pubmed: 25329662
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12411-12418
pubmed: 32430323
JAMA Netw Open. 2020 Jun 1;3(6):e207922
pubmed: 32597992
J Clin Endocrinol Metab. 2014 Nov;99(11):4116-23
pubmed: 25148233

Auteurs

Joshua I Barzilay (JI)

Division of Endocrinology, Kaiser Permanente of Georgia and the Division of Endocrinology, Emory University School of Medicine, Atlanta, GA, United States of America. Electronic address: joshua.barzilay@kp.org.

Alokananda Ghosh (A)

The Biostatistics Center, Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, The George Washington University, Rockville, MD, United States of America.

Rodica Pop Busui (RP)

Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States of America.

Andrew Ahmann (A)

Division of Endocrinology, Diabetes & Clinical Nutrition, Oregon Health & Science University, Portland, OR, United States of America.

Ashok Balasubramanyam (A)

Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX, United States of America.

Mary Ann Banerji (MA)

State University of New York Downstate Medical Center, Kings County Hospital, Brooklyn, NY, United States of America.

Robert M Cohen (RM)

Division of, Endocrinology, Diabetes, and Metabolism, University of Cincinnati College of Medicine and Cincinnati VA Medical Center, Cincinnati, OH, United States of America.

Jennifer Green (J)

Department of Medicine, Division of Endocrinology, Duke University Medical Center, Durham, NC, United States of America.

Faramarz Ismail-Beigi (F)

Division of Endocrinology, Case Western Reserve University and Cleveland VA Medical Center, Cleveland, OH, United States of America.

Catherine L Martin (CL)

Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States of America.

Elizabeth Seaquist (E)

Division of Diabetes and Endocrinology, Department of Medicine, University of Minnesota, Minneapolis, MN, United States of America.

José A Luchsinger (JA)

Columbia University Irving Medical Center, Department of Medicine, New York, NY, United States of America; Columbia University Irving Medical Center, Department of Epidemiology, New York, NY, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH